In a Different Vein: News From the Blood Journals Portfolio

Recent research from ASH’s Blood journals

For articles on research from Blood and Blood Advances published prior to May 2024, visit Written in Blood and Blood Advances in a Different Vein.

Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Respond Well to Asciminib, Dasatinib

Lara C. Pullen, PhD

Soluble Anti-B-Cell Maturation Antigen, High Disease Burden Modulate Responses in Patients With MM Receiving BCMA T-Cell–Engager Therapy

Lara C. Pullen, PhD

Experts Release Guidance on Liver-Related Toxicities With Gene Therapy for Hemophilia A

Anna Azvolinsky, PhD

Venetoclax Effective for Bridging to Transplant in R/R AML, Study Suggests

Thomas R. Collins

New Therapy May Be Effective for Patients With Cold Agglutinin Disease, Warm Antibody Autoimmune Hemolytic Anemia

Anna Azvolinsky, PhD

Genetics-Based Risk Model to Stratify Survival Outcomes of Patients With AML Treated With Venetoclax-Azacitidine

Anna Azvolinsky, PhD

Better Preventive Stroke Management Needed for SCD

Ruth Jessen Hickman, MD

Pediatric T-LBL But Not T-ALL Harbors TRB::NOTCH1 Fusions With Increased Relapse Risk

Katie Robinson

SCD Gene Therapies Present Major Challenges to State Medicaid Budgets

Ruth Jessen Hickman, MD

Teclistamab Elicits Responses in Patients With Multiple Myeloma Previously Treated With BCMA-Targeted Therapy

Anna Azvolinsky, PhD

Fixed-Duration Regimen Safe, Effective for CLL

Lara C. Pullen, PhD

Iron Deficiency Remains Unresolved Years After Diagnosis

Anna Azvolinsky, PhD

Study Examines Development of Paraparesis, Quadriparesis in Pediatric Patients With B-ALL Treated With CAR T-Cell Therapy

Anna Azvolinsky, PhD

Molecular Taxonomy of MDS May Help Guide Clinical Decisions, Trials

Katie Robinson

HCT Shows Better Outcomes in Young Pediatric Patients With Fanconi Anemia

Lara C. Pullen, PhD

Cognitive Dysfunction Can Lurk After Remission of Complement-Mediated Thrombotic Microangiopathy

Lara C. Pullen, PhD

Study Offers New Hope for Pregnancy After AlloHCT

Leah Lawrence

Study of Patients with Myelodysplastic Syndromes Questions Need for Induction Therapy Before AlloHCT

Anna Azvolinsky, PhD

Dose-Adjusted VEN-HMA Regimens Safe, Effective in Very Old Patients With AML

Leah Lawrence

VCDD Combination Therapy Effective for Non-Transplant Eligible Patients With Myeloma

Lara C. Pullen, PhD

1 2

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
Mid-November 2024

Advertisement intended for health care professionals

In a Different Vein: News From the Blood Journals Portfolio

ASH Publications

American Society of Hematology

In a Different Vein: News From the Blood Journals Portfolio

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only